Galmed Pharmaceuticals (GLMD) PT Lowered to $15 at SunTrust Robinson Humphrey, Keeps 'Buy'
Tweet Send to a Friend
SunTrust Robinson Humphrey lowered its price target on Galmed Pharmaceuticals (NASDAQ: GLMD) to $15.00 (from $19.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
